IOVANCE BIOTHERAPEUT

IOVA
Delayed Quote. Delayed  - 07/28 04:00:00 pm
22.92USD +4.99%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Diagnostics & Testing
Iovance Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to eradicate cancer cells. The Company has developed a shorter manufacturing process for Tumor infiltrating lymphocyte (TIL) therapy known as Generation 2 (Gen 2), which yields a cryopreserved TIL product. Its lead product candidates include lifileucel for metastatic melanoma and LN-145 for metastatic cervical cancer. In addition to metastatic melanoma and metastatic cervical cancer, it is investigating TIL therapy and peripheral blood lymphocyte therapy for the treatment of squamous cell carcinoma of the head and neck, non-small cell lung cancer and chronic lymphocytic leukemia.

Number of employees : 241 people.
Managers
Name Title
Frederick G. Vogt President, CEO, Secretary & General Counsel
Jean-Marc Bellemin CFO & Principal Accounting Officer
Iain David Dukes Chairman
Friedrich Graf Finckenstein Chief Medical Officer
Igor P. Bilinsky Chief Operating Officer
Merrill A. McPeak Independent Director
Ryan D. Maynard Independent Director
Wayne P. Rothbaum Independent Director
Michael Weiser Independent Director
Athena Countouriotis Independent Director
Shareholders
Name Equities %
ARK Investment Management LLC 21,762,475 14.2%
The Vanguard Group, Inc. 12,388,066 8.10%
Franklin Advisers, Inc. 9,581,421 6.27%
Quogue Capital LLC 9,000,000 5.89%
Wellington Management Co. LLP 6,803,987 4.45%
BlackRock Fund Advisors 6,460,180 4.23%
T. Rowe Price Associates, Inc. (Investment Management) 4,391,318 2.87%
DWS Investments (UK) Ltd. 3,797,200 2.48%
Geode Capital Management LLC 2,396,208 1.57%
Lord, Abbett & Co. LLC 2,383,365 1.56%
Company contact information
Iovance Biotherapeutics, Inc.
999 Skyway Road
Suite 150
San Carlos, CA 94070

Phone : +1.650.260.7120
Web : http://www.iovance.com
Sector Bio Diagnostics & Testing
1st jan.Capi. (M$)
IOVANCE BIOTHERAPEUTICS, INC.-52.95%3 337
EXACT SCIENCES CORPORATION-15.50%19 205
GUARDANT HEALTH, INC.-14.91%11 089
BGI GENOMICS CO., LTD.-19.10%6 080
INVITAE CORPORATION-35.18%5 416
ADAPTIVE BIOTECHNOLOGIES CORPORATION-40.10%4 970
CAREDX, INC15.24%4 346
SEEGENE, INC.-25.39%3 343
VERACYTE, INC.-23.99%2 502
BEIJING STRONG BIOTECHNOLOGIES, INC.-28.06%1 628
Q-LINEA AB (PUBL)-8.24%530
ASPIRA WOMEN'S HEALTH INC.-29.81%527
CELCUITY INC.121.62%302
BIOVICA INTERNATIONAL AB (PUBL)7.62%182
ANPAC BIO-MEDICAL SCIENCE CO., LTD.-28.87%53
LYSOGENE-19.62%41
SPAGO NANOMEDICAL AB (PUBL)0.00%34
EPIGENOMICS AG-62.94%18